We are studying how MP-101 affects laboratory signs of ALS and Alzheimer's in patients. This research aims to gather insights on its potential impact on these diseases.
Health conditions and diseases that the clinical trial is designed to study and treat.
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, difficulty speaking, and eventually loss of mobility.
Alzheimer’s Disease (AD) is a progressive brain disorder that slowly destroys memory and thinking skills, eventually interfering with daily tasks. It is the most common cause of dementia.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.